XRAYMEDIA Europe Expands the Center of Innovation Technology's Team of Top Professionals with Anesthesiologist Dr. Norbert Smeets.

NEW YORK & VANCOUVER, British Columbia -- XRAYMEDIA, Inc. (OTCBB: XRYM), an industry leader in real-time negotiating technology, is proud to announce that the Company has recently signed Dr. Norbert Smeets as its first consultant to XRAYMEDIA's Center of Innovation Technology. Dr. Smeets will provide insights and recommendations on new technologies registered at the Center of Innovation Technology site. He has many years of experience working as an Anesthesiologist and presently acts as the management coordinator of Anesthesiology for all hospital and hospitalization disciplines within Medical Spectrum Twente, which belongs to the largest not-academic hospitals of The Netherlands. At present, Medical Spectrum Twente has hospital locations at Enschede and Oldenzaal in the Netherlands. Within Medical Spectrum Twente work approximately 4000 employees, hereunder 200 specialists. Medical Spectrum Twente works with an annual budget of approximately EUR190,000,000. Dr. Smeets will provide XRAYMEDIA with his expertise while helping to structure the success of the Center of Innovation Technology. Please visit www.mstwente.nl/anesthesiologie/onze_specialisten/smeets/ for more information. Dr. Norbert Smeets will utilize his medical advisory role to support XRAYMEDIA in the research and development of emerging technologies within the Center of Innovation Technology, focusing primarily within his own discipline on Biology, medicine, society, and sciences department.

XRAYMEDIA European LOM President & CEO Mr. Hans Johannes Schulte remarks: "We are overwhelmed with the response we are receiving among industry experts such as Mr. Norbert Smeets, and he is an outstanding addition to our team. His medical expertise will greatly enhance our assessments of technology within his industry. We believe that market development must occur in tandem with technology development. Presently, our internal and external teams of experts are working alongside entrepreneurs to accelerate market development and position innovative business opportunities for long-term success. With the expertise and assistance made available by our international network of industry professionals, the Center of Innovation Technology is designed to impact technology industries worldwide."

Dr. Norbert Smeets comments on his appointment: "I am very pleased to initially take this post. The Center of Innovation Technology is an outstanding growth tool for economic development and research advancements, we all know how important this is. I am honored to become a part of this important venture, at this point The Center of Innovation technology is being populated with well over 1000 unique company listings from the Office of the European Community, Research and Development Information Service, CORDIS Unit. Each of these companies will be looking for R&D progress, collaborations and partnerships, marketing and/or initial or secondary financing. XRAYMEDIA has analyzed the market and we expect to discover many emerging ideas and developments. The Center of Innovation Technology will utilize multiple Venture Exchange Networks to further empower entrepreneurs through the technology platform. In developing The Center of Innovation Technology, it is our intention to address the needs of both entrepreneurs and investors in the online venture and media exchange that is empowered by XRAYMEDIA's unique hybrid online technology. The Center of Innovation Technology will serve to support the ambitions of entrepreneurs worldwide."

Mr. Schulte concludes with: "The Center of Innovation Technology will act as a pseudo Venture Capital Group, and will act as a collaborative project liaison for the Office of the European Community, Research and Development Information Service, CORDIS Unit, to aid in stimulating European-wide access to the U.S. by improving the financing pipeline from the U.S. and other countries worldwide. In combination with our unique live negotiating platform we will provide as an alliance, an international banking facility. By coupling a flow of funds and technology development with each other we can accelerate a sustainable socio-economic development in conjunction within the frame of The Sixth Framework Programme for research (FP6). FP6 is the European Union's main instrument to promote and support research and development in Europe from 2002 until now. With a budget of EUR17,500 million -- an increase of 17% on the Fifth Framework Programme -- FP6 represents the EU's third-largest operational budget, after the Common Agricultural Policy and the Structural Funds. With this and other powerful advancements we are making, this is a very exciting time for all XRAYMEDIA shareholders."

Please visit http://europa.eu.int/comm/research/fp6/index_en.cfm?p=0 for more information on the FP6 program.

You should not place undue reliance on forward-looking statements in this press release. This press release contains forward-looking statements that involve risks and uncertainties. Words such as "will," "anticipates," "believes," "plans," "goal," "expects," "future," "intends" and similar expressions are used to identify these forward-looking statements. Actual results could differ materially from those anticipated in these forward-looking statements for many reasons, including the risks we face as described in this press release. For further information about XRAYMEDIA, INC., please refer to its Form 10-ksb filed with the Securities and Exchange Commission and available on the SEC website at www.sec.gov.